Law Firm Launches Investigation Into Alignment Healthcare Over Alleged Accounting Irregularities
Kaplan Fox & Kilsheimer LLP has initiated an investigation into potential securities law violations by Alignment Healthcare, Inc. (NASDAQ: ALHC), a Medicare Advantage health plan provider founded in 2013 and headquartered in Orange, California. The company serves approximately 135,000 members across multiple states.
The investigation follows a whistleblower complaint filed on July 8, 2026, by a former Alignment Healthcare executive. The complaint alleges the company engaged in accounting irregularities that artificially inflated previously reported and projected financial results, including Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA), a key performance metric used in executive compensation calculations.
According to the lawsuit, millions of dollars in operating expenses were systematically misclassified as capital expenditures. Such misclassification can create a misleading picture of operational performance, as capital expenditures are typically excluded from operating expense calculations and depreciated over time, while operating expenses directly reduce earnings measures like EBITDA.
Market Response and Investor Impact
Following the whistleblower complaint disclosure, Alignment Healthcare's stock price fell $4.02 per share, or 16.7%, closing at $20.03 on July 8, 2026. The company went public through an initial public offering on March 25, 2021, at $18 per share, raising approximately $439 million.
Whistleblower complaints can trigger Securities and Exchange Commission investigations and enforcement actions. The SEC's Office of the Whistleblower, established under the Dodd-Frank Act, has awarded over $2 billion to whistleblowers since 2012, demonstrating the program's significance in uncovering corporate misconduct.
Regulatory Framework and Industry Context
Under the Securities Exchange Act of 1934, particularly Section 10(b) and Rule 10b-5, companies and executives can face civil and criminal liability for making material misrepresentations or omissions in financial statements that deceive investors.
The allegations carry particular significance given the scale of the Medicare Advantage industry. Medicare Advantage plans received approximately $454 billion in federal payments in 2024, representing roughly half of all Medicare beneficiaries. Financial reporting accuracy in this sector matters not only to investors but also to federal regulators and taxpayers.
Investigation Details
Kaplan Fox & Kilsheimer LLP, a nationally recognized law firm founded in 1956, is conducting the investigation. The firm has secured major recoveries in securities litigation, including a $2.425 billion settlement in a Bank of America case—one of the largest securities settlements in U.S. history.
The firm is seeking information from Alignment Healthcare investors who have suffered losses and individuals who may have relevant information about the alleged accounting practices. Class action securities lawsuits following stock price declines typically have statute of limitations periods ranging from one to three years, depending on when investors discovered or should have discovered the fraud.
Investors can contact the firm through its website or by contacting attorneys Pamela A. Mayer in New York or Laurence D. King in Oakland, California. The firm emphasizes that contacting them does not create an attorney-client relationship or obligation to retain their services.
